Modeling the dynamics of oral poliovirus vaccine cessation (Q42183580)

18 October 2017

Modeling the dynamics of oral poliovirus vaccine cessation (English)

1 reference

Radboud J Duintjer Tebbens

18 October 2017

0 references

1 reference

series ordinal

2

object named as

Radboud J Duintjer Tebbens

1 reference

18 October 2017

1

Kimberly M Thompson

1 reference

PubMed ID

25316870

18 October 2017

language of work or name

English

0 references

publication date

1 November 2014

1 reference

Journal of Infectious Diseases

18 October 2017

1 reference

18 October 2017

210 Suppl 1

1 reference

18 October 2017

S475-84

1 reference

Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication.

18 October 2017

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Oral poliovirus vaccine evolution and insights relevant to modeling the risks of circulating vaccine-derived polioviruses (cVDPVs).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Modeling population immunity to support efforts to end the transmission of live polioviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Evaluation of response scenarios to potential polio outbreaks using mathematical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Modeling poliovirus risks and the legacy of polio eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Modeling the potential role of inactivated poliovirus vaccine to manage the risks of oral poliovirus vaccine cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Modeling strategies to increase population immunity and prevent poliovirus transmission in the high-risk area of northwest Nigeria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Modeling strategies to increase population immunity and prevent poliovirus transmission in 2 high-risk areas in northern India

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Characterizing poliovirus transmission and evolution: insights from modeling experiences with wild and vaccine-related polioviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

The potential impact of expanding target age groups for polio immunization campaigns

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

On the definition and the computation of the basic reproduction ratio R0 in models for infectious diseases in heterogeneous populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Expert review on poliovirus immunity and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

National choices related to inactivated poliovirus vaccine, innovation and the endgame of global polio eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

Preeradication vaccine policy options for poliovirus infection and disease control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIT845

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIT845

1 reference

18 October 2017

1 reference

PubMed ID

25316870